Lamb model of respiratory syncytial virus-associated lung disease: Insights to pathogenesis and novel treatments

ILAR Journal

Volumn 55, Issue 1, 2014, Pages 4-15

  Ackermann, Mark R ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Bronchiolitis; Infants; Lambs; Pneumonia; Preterm; Respiratory syncytial virus (RSV)

Indexed keywords

ALCOHOL; VASCULOTROPIN A; VIRUS VACCINE;

ANIMAL; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SHEEP; VIROLOGY; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; ETHANOL; HUMANS; LUNG; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SHEEP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84902460865     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar/ilu003     Document Type: Article

References (104)

1. Abed Y, Boivin G. 2006. Treatment of respiratory virus infections. Antiviral Res 70:1-16.
2. Albertsen K, Gronbaek M. 2004. Alcohol consumption during pregnancy and the risk of preterm delivery. Am J Epidemiol 159:155-161.
3. Alcorn DG, Adamson TM, Maloney JE, Robinson PM. 1981. Amorphologic and morphometric analysis of fetal lung development in the sheep. Anat Rec 201:655-667.
4. Anderson LJ. 2013. Respiratory syncytial virus vaccine development. Semin Immunol. 25:160-171.
5. Aujard Y, Fauroux B. 2002. Risk factors for severe respiratory syncytial virus infection in infants. Resp Med 96:S9-S14.
6. Bae YS, Choi MK, Lee W-J. 2010. Dual oxidase in mucosal immunity and host-microbe homeostasis. Trends Immunol 31:278-287.
7. Banfi B. 2007. A novel host defense system of airways is defective in cystic fibrosis: Update. Am J Resp Crit Care Med 175:967-976.
8. Barth PJ, Wolf M, Ramaswamy A. 1994. Distribution and number of Clara cells in the normal and disturbed development of the human fetal lung. Pediatr Pathol 14:637-651.
9. Belding ME, Klebanoff SJ, Ray CG. 1970. Peroxidase-mediated virucidal systems. Science 167:195-196.
10. Bem RA, Domachowske JB, Rosenberg HF. 2011. Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol 301:L148-L156.
11. Blanken MO, Rovers MM, Bont L; Dutch RSV Neonatal Network. 2013. Respiratory syncytial virus and recurrent wheeze. N Engl J Med. 369:782-783.
12. Bozeman PM, Learn DB, Thomas EL. 1992. Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone. Biochem Pharm 434:553-563.
13. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ. 2001. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 281:L1001-L1001.
14. Castilow EM, Olson MR, Varga SM. 2007. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. Immunol Res 39:225-239.
15. Chang S, Linderholm A, Franzi L, Kenyon N, Grasberger H, Harper R. 2013. Dual oxidase regulates recruitment in allergic airways. Free Radic Biol Med. 65C:38-46.
16. Collins PL, Graham BS. 2008. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82:2040-2055.
17. Collins PL, Melero JA. 2011. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years. Virus Res 162:80-99.
18. Conner GE, Salathe M, Forteza R. 2002. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am J Respir Crit Care Med 166: S57-S61.
19. Conner GE, Wijkstrom-Frei C, Randell SH, Fernandez VE, Salathe M. 2007. The lactoperoxidase system links anion transport to host defense in cystic fibrosis. FEBS Lett 581:271-278.
20. Costello HM, Ray WC, Chaisatpongsakron S, Peeples ME. 2012. Targeting RSV with vaccines and small molecule drugs. Infect Disord Drug Targets 12:110-128.
21. Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, Batalle JP, Diaz L, Trento A, Chang HY, Mitzner W, Ravetch J, Melero JA, Irusta PM, Polack FP. 2009. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15:34-41.
22. Derscheid RJ, Ackermann MR. 2012. Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses 4:2359-2378.
23. Derscheid RJ, Ackermann MR. 2013. The innate immune system of the perinatal lung and responses to respiratory syncytial virus infection. Vet Pathol 50:827-841.
24. Derscheid RJ, Gallup JM, Knudson CJ, Varga SM, Grosz DD, van Geelen A, Hostetter J, Ackermann MR. 2014. Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV. PLOS One 8:e81472.
25. Derscheid RJ, van Geelen A, Gallup JM, Hostetter SJ, Banfi B, McCray PB Jr, Ackermann MR. 2013. Increased concentration of iodide in airway secretions is associated with reduced RSV disease severity. Am J Resp Cell Mol Biol 50:389-397.
26. Derscheid RJ, van Geelen A, McGill JL, Gallup JM, Cihlar T, Sacco RE, Ackermann MR. 2013. Human respiratory syncytial virus Memphis 37 grown in HEp-2 cells causes more severe disease in lambs than virus grown in Vero cells. Viruses 22:2881-2897.
27. DeVincenzo JP, Wilkinson T, Vaishnaw A, Cehelsky J, Meyers R, Nochur S, Harrison L, Meeking P, Mann A, Moane E, Oxford J, Pareek R, Moore R, Walsh E, Studholme R, Dorsett P, Alvarez R, Lambkin-Williams R. 2010. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med 182:1305-1314.
28. Dohán O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. 2003. The sodium/iodide symporter (NIS): Characterization, regulation, and medical significance. Endocr Rev 24:48-77.
29. Elizur A, Adair-Kirk TL, Kelley DG, Griffin GL, deMello DE, Senior RM. 2007. Clara cells impact the pulmonary innate immune response to lps. Am J Physiol Lung Cell Mol Physiol 293:L383-L392.
30. Empey KM, Peebles RS Jr, Kolls JK. 2010. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin Infect Dis 50:1258-1267.
31. Espinoza JA, Bohmwald K, Céspedes PF, Gómez RS, Riquelme SA, Cortés CM, Valenzuela JA, Sandoval RA, Pancetti FC, Bueno SM, Riedel CA, Kalergis AM. 2013. Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci U S A 110:9112-9117.
32. Ethen MK, Ramadhani TA, Scheuerle AE, Canfield MA, Wyszynski DF, Druschel CM, Romitti PA. 2009. Alcohol consumption by women before and during pregnancy. Matern Child Health J 13:274-285.
33. Eyles JE, Johnson JE, Megati S, Roopchand V, Cockle PJ, Weeratna R, Makinen S, Brown TP, Lang S, Witko SE, Kotash CS, Li J, West K, Maldonado O, Falconer DJ, Lees C, Smith GJ, White P, Wright P, Loudon PT, Merson JR, Jansen KU, Sidhu MK. 2013. Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus. J Infect Dis. 208:319-329.
34. Fach SJ, Brockmeier SL, Hobbs LA, Lehmkuhl HD, Sacco SE. 2007. Pulmonary dendritic cells isolated from neonatal and adult ovine lung tissue. Vet Immunol Immun Pathol 112:171-182.
35. Fach SJ, Meyerholz DK, Gallup JM, Ackermann MR, Lehmkuhl HD, Sacco RE. 2007. Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 and IL-10 gene transcripts. Viral Immunol 20:119-130.
36. Fach SJ, Olivier A, Gallup JM, Waters TE, Ackermann MR, Lehmkuhl HD, Sacco RE. 2010. Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Vet Immunol Immunopathol 136:55-64.
37. Fischer AJ, Lennemann NJ, Krishnamurthy S, Pocza P, Durairaj L, Launspack JL, Rhein BA, Wohlford-Lenane C, Lorentzen D, Banfi B, McCray PB Jr. 2011. Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide. Am J Respir Cell Mol Biol 45:874-881.
38. Fischer H. Mechanism and function of DUOX in epithelia of the lung. 2009. Antioxid Redox Signal 11:2453-2465.
39. Fischer H, Gonzales LK, Kolla V, Schwarzer C, Miot F, Illek B, Ballard PL. 2007. Developmental regulation of Duox1 expression and function in human fetal lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 292: L1506-L1514.
40. Flecknoe SL, Wallace MJ, Cock ML, Harding R, Hooper SB. 2003. Changes in alveolar epithelial cell proportions during fetal and postnatal development in sheep. Am J Physiol Lung Cell Mol Physiol 285:L664-L679.
41. Forteza R, Salathe M, Miot F, Forteza R, Conner GE. 2005. Regulated hydrogen peroxide production by Duox in human airway epithelial cells. Am J Respir Cell Mol Biol 32:462-469.
42. Fragoso MA, Fernandez V, Forteza R, Randell SH, Salathe M, Conner GE. 2004. Transcellular thiocyanate transport by human airway epithelia. J Physiol 561:183-194.
43. Furtmüller PG, Jantschko W, Regelsberger G, Jakopitsch C, Arnhold J, Obinger C. 2002. Reaction of lactoperoxidase compound I with halides and thiocyanate. Biochemistry 41:11895-11900.
44. Gallup JM, Kawashima K, Lucero G, Ackermann MR. 2005. New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR. Biol Proced Online 7:70-92.
45. Garcia CG, Bhore R, Soriano-Fallas A, Trost M, Chason R, Ramilo O, Mejias A. 2010. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 126:e1453-1460.
46. Gattas MV, Forteza R, Fragoso MA, Fregien N, Salas P, Salathe M, Conner GE. 2009. Oxidative epithelial host defense is regulated by infectious and inflammatory stimuli. Free Radic Biol Med: 47:1450-1458.
47. Gershwin LJ. 2012. Immunology of bovine respiratory syncytial virus infection of cattle. Comp Immunol Microbiol Infect Dis 35:253-257.
48. Gerson C, Sabater J, Scuri M, Torbati A, Coffey R, Abraham JW, Lauredo I, Forteza R, Wanner A, Salathe M, Abraham WM, Conner GE. 2000. The lactoperoxidase system function in bacterial clearance of airways. Am J Resir Cell Mol Biol 22:665-671.
49. Guo-Parke H, Canning P, Douglas I, Villenave R, Heaney LG, Coyle PV, Lyons JD, Shields MD, Power UF. 2013. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med. 188:842-851.
50. Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, Poehling KA, Szilagyi PG, Griffin MR, Williams JV, Zhu Y, Grijalva CG, Prill MM, Iwane MK. 2013. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 132: e341-348.
51. Harper RW, Xu C, Eiserich JP, Chen Y, Kao CY, Thai P, Setiadi H, Wu R. 2005. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 579:4911-4917.
52. Hon KL, Leung TF, Cheng WY, Ko NM, Tang WK, WongWW, Yeung WH, Chan PK. 2012. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J Crit Care 27:464-468.
53. Hosakote YM, Komaravelli N, Mautemps N, Liu T, Garafalo RP, Casola A. 2012. Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus. Am J Resp Lung Cell Mol Physiol 303:L991-L1000.
54. Jaddoe VW, Bakker R, Hofman A, Mackenbach JP, Moll HA, Steegers EA, Witteman JC. 2007. Moderate alcohol consumption during pregnancy and the risk of low birth weight and preterm birth. The Generation R study. Ann Epidemiol 17:834-840.
55. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. 2007. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20:108-119.
56. Kawashima K, Meyerholz DK, Gallup JM, Grubor B, Lazic T, Lehmkuhl HD, Ackermann MR. 2006. Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol 19:316-323.
57. Klebanoff SJ. 1967. Iodination of bacteria: a bactericidal mechanism. J Exp Med 126:1063-1078.
58. Krishnan S, Craven M, Welliver RC, Ahmad N, Halonen M. 2003. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. J Infect Dis 188:433-439.
59. Lazic T, Matic M, Gallup JM, Van Geelen A, Meyerholz DK, Grubor B, Imerman PM, Almeida de Macedo MM, Ackermann MR. 2010. Effects of nicotine on pulmonary surfactant proteins A and D in ovine lung epithelia. Pediatr Pulmonol 45:255-262.
60. Lazic T, Sow FB, Van Geelen A, Meyerholz DK, Gallup JM, Ackermann MR. 2011. Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of fetal lung. Alcohol 45:673-680.
61. Lazic T, Wyatt TA, Matic M, Meyerholz DK, Grubor B, Gallup JM, Kersting KW, Imerman PM, Almeida-De-Macedo M, Ackermann MR. 2007. Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia. Alcohol 41:347-355.
62. Lehmkuhl HD, Cutlip RC. 1979a. Experimental respiratory syncytial virus infection in feeder-age lambs. Am J Vet Res 40:1729-1730.
63. Lehmkuhl HD, Cutlip RC. 1979b. Experimentally induced respiratory syncytial virus infection in lambs. Am J Vet Res 40:512-544.
64. Lorentzen D, Durairaj L, Pezzulo AA, Nakano Y, Launspach J, Stoltz DA, Zamba G, McCray PB Jr, Zabner J, Welsh MJ, Nauseef WM, Bánfi B. 2011. Concentration of the antibacterial precursor thiocyanate in cystic fibrosis airway secretions. Free Radic Biol Med. 50:1144-1150.
65. McGowan SE, Snyder JM. 2004. Development of alveoli, In: Harding R, Pinkerton KE, Plopper CG, eds. The Lung Development, Aging and the Environment. Waltham, MA: Elsevier Academic Press. p 55-73.
66. McLellan JS, Chen M, Joyce MG, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Chen L, Srivatsan S, Zheng A, Zhou T, Graepel KW, Kumar A, Moin S, Boyington JC, Chuang GY, Soto C, Baxa U, Bakker AQ, Spits H, Beaumont T, Zheng Z, Xia N, Ko SY, Todd JP, Rao S, Graham BS, Kwong PD. 2013. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342:592-598.
67. Meehan JT, Cutlip RC, Lehmkuhl HD, Kluge JP, Ackermann MR. 1994. Infected cell types in ovine lung following exposure to bovine respiratory syncytial virus. Vet Pathol 31:229-236.
68. Mestas J, Hughes CCW. 2004. Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731-2738.
69. Meyerholz DK, DeGraaff JA, Gallup JM, Ackermann MR. 2006. Depletion of alveolar glycogen corresponds with immunohistochemical development of CD208 antigen expression in perinatal lamb lung. J Histochem Cytochem 54:1247-1253.
70. Meyerholz DK, Gallup JM, Lazic T, de Macedo MMA, Lehmkuhl HD, Ackermann MR. 2007. Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of RSV infection. Viral Immunol 20:188-196.
71. Meyerholz DK, Grubor B, Fach SJ, Sacco RE, Lehmkuhl HD, Gallup JM, Ackermann MR. 2004. Reduced clearance of respiratory syncytial virus in a preterm lamb model. Microbes Infection 6:1312-1319.
72. Meyerholz DK, Grubor B, Gallup JM, Lehmkuhl HD, Anderson RD, Lazic T, Ackermann MR. 2004. Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs. J Clin Micro 42:4780-4787.
73. Meyerholz DK, Grubor B, Lazic T, Gallup JM, de Macedo MMA, McCray PB Jr., Ackermann MR. 2006. Monocytic/macrophagic pneumonitis following intrabronchial deposition of vascular endothelial growth factor in neonatal lambs. Vet Pathol 43:689-694.
74. Meyerholz DK, Kawashima K, Gallup J, Grubor B, Ackermann MR. 2006. Expression of innate immune genes (SP-AD, SBD-1, TLR4) by respiratory epithelia at preterm gestation is less than full-term. Dev Comp Immunol. 30:1060-1069.
75. Moskwa P, Lorentzen D, Excoffon KJDA, Zabner J, McCray PB Jr, Nauseef WM, Dupuy C, Banfi B. 2007. A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 175:174-183.
76. Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, Simmerman JM, Gordon A, Sato M, Howie S, Krishnan A, Ope M, Lindblade KA, Carosone-Link P, Lucero M, Ochieng W, Kamimoto L, Dueger E, Bhat N, Vong S, Theodoratou E, Chittaganpitch M, Chimah O, Balmaseda A, Buchy P, Harris E, Evans V, Katayose M, Gaur B, O'Callaghan-Gordo C, Goswami D, Arvelo W, Venter M, Briese T, Tokarz R, Widdowson MA, Mounts AW, Breiman RF, Feikin DR, Klugman KP, Olsen SJ, Gessner BD, Wright PF, Rudan I, Broor S, Simões EA, Campbell H. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet 375:1545-1555.
77. Nauseef WM. 2013. Detection of superoxide anion and hydrogen peroxide production by cellular NADPH oxidases. Biochimica Biophysica Acta 1840:757-767.
78. Olivier A, Gallup JM, de Macedo MM, Varga SM, Ackermann MR. 2009. Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. Int J Exp Pathol 90:431-438.
79. Olivier A, Gallup JM, van Geelen A, Ackermann MR. 2011. Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus A2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res 37:131-143.
80. Pack RJ, Al-Ugaily LH, Morris G, Widdicombe JG. 1980. The distribution and structure of cells in the tracheal epithelium of the mouse. Cell Tissue Res 208:65-84.
81. Pickles RJ. 2013. Human airway epithelial cell cultures for modeling respiratory syncytial virus infection. Curr Top Microbiol Immunol. 372:371-387.
82. Plopper CG, Mariassy AT, Lollini LO. 1983. Structure as revealed by airway dissection. A comparison of mammalian lungs. Am Rev Respir Dis 128: S4-S7.
83. Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL. 2013. Respiratory syncytial virus: Current progress in vaccine development. Viruses 5:577-594.
84. Sacco RE, McGill JL, Pillatzki AE, Palmer MV, Ackermann MR. 2013. Respiratory syncytial virus infection in cattle. Vet Pathol 51:427-436.
85. Scheerlinck J-P Y, Snibson KJ, Bowles VM, Sutton P. 2008. Biomedical applications of sheep models: from asthma to vaccines. Trends Biotech 26:259-266.
86. Sommer C, Resch B, Simoes EA. 2012. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. J Open Microbiol 5:144-154.
87. Sow FB, Gallup JM, Derscheid R, Krishnan S, Ackermann MR. 2012. Ontogeny of the immune response in the ovine lung. Immunological Investigations. 41:304-316.
88. Sow FB, Gallup JM, Krishnan S, Patera AC, Suzich J, Ackermann MR. 2010. Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs. Respir Res 12:106
89. Sow FB, Gallup JM, Meyerholz DK, Ackermann MR. 2009. Gene profiling studies in the neonatal ovine lung show enhanced effects of VEGF on the immune response. Dev Comp Immunol 33:761-771.
90. Sow FB, Gallup JM, Olivier A, Krishnan S, Patera AC, Suzich J, Ackermann MR. 2011. Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lungdraining lymph nodes of newborn lambs. Am J Physiol Lung Cell Mol Physiol 300:L12-24.
91. Sow FB, Gallup JM, Sacco R, Ackermann MR. 2009. Laser capture microdissection revisited as a tool for transcriptomic analysis: application of an Excel-based qPCR preparation software (PREXCEL-Q). Int J Biomed Sci 5:105-124.
92. Sozo F, O'Day L, Maritz G, Kenna K, Stacy V, Brew N, Walker D, Bocking A, Brien J, Harding R. 2009. Repeated ethanol exposure during late gestation alters the maturation and innate immune status of the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 296:L510-L518.
93. Stark JM, Stark MA, Colasurdo GN, LeVine AM. 2006. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection. J Med Viol 78:829-838.
94. Starner TD, Agerberth B, Gudmundsson GH, McCray PB Jr. 2005. Expression and activity of beta defensins and LL-37 in the developing human lung. J Immunol 174:1608-1615.
95. Stokes KL, Currier MG, Sakamoto K, Lee S, Collins PL, Plemper RK, Moore ML. 2013. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. J Virol 87:10070-10082.
96. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17:1132-1136.
97. van den Bergh MR, Biesbroek G, Rossen JW, de Steenhuijsen Piters WA, Bosch AA, van Gils EJ, Wang X, Boonacker CW, Veenhoven RH, Bruin JP, Bogaert D, Sanders EA. 2012. Associations between pathogens in the upper respiratory tract of young children: Interplay between viruses and bacteria. PLoS One 7:e47711.
98. Villenave R, Shields MD, Power UF. 2013. Respiratory syncytial virus interaction with human airway epithelium. Trends Microbiol 21:238-244.
99. Voelkel NF, Vandivier RW, Tuder RM. 2006. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 290:L209-L221.
100. Wang SZ, Rosenberger CL, Bao YX, Stark JM, Harrod KS. 2003. Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection. J Immunol 171:1051-1060.
101. Welliver RC, Checchia PA, Bauman JH, Fernandes AW, Mahadevia PJ, Hall CB. 2010. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Curr Med Res Opin 26:2175-2181.
102. Widdicombe JH, Chen LL, Sporer H, Choi HK, Pecson IS, Bastacky SJ. 2001. Distribution of tracheal and laryngeal mucous glands in some rodents and the rabbit. J Anat 198:207-221.
103. Wijkstrom-Frei C, El-Chemaly S, Ali-Rachedi R, Gerson C, Cobas MA, Forteza R, Salathe M, Conner GE. 2003. Lactoperoxidase and human airway host defense. Am J Respir Cell Mol Biol 29:206-212.
104. Wu H, Pfrarr DS, Losonsky GA, Kiener PA. 2008. Immunoprophylaxis of RSVinfection: advancing from RSV-IGIV to palivizumab and motavizumab. Curr Top Microbiol Immunol 317:103-123.